TY - JOUR
T1 - Newer Technologies in Breast Cancer Imaging
T2 - Dedicated Cone-Beam Breast Computed Tomography
AU - O'Connell, Avice M.
AU - Karellas, Andrew
AU - Vedantham, Srinivasan
AU - Kawakyu-O'Connor, Daniel T.
N1 - Funding Information:
This work was supported by the National Cancer Institute (NCI) of the National Institutes of Health (NIH) Grants R21 CA134128, R01 CA195512, and R01 CA199044. The contents are solely the responsibility of the authors and do not represent the official views of the NIH or NCI.
Publisher Copyright:
© 2018 Elsevier Inc.
PY - 2018/2
Y1 - 2018/2
N2 - Dedicated breast computed tomography (CT) is the latest in a long history of breast imaging techniques dating back to the 1960s. Breast imaging is performed both for cancer screening as well as for diagnostic evaluation of symptomatic patients. Dedicated breast CT received US Food and Drug Administration approval for diagnostic use in 2015 and is slowly gaining recognition for its value in diagnostic 3-dimensional imaging of the breast, and also for injected contrast-enhanced imaging applications. Conventional mammography has known limitations in sensitivity and specificity, especially in dense breasts. Breast tomosynthesis was US Food and Drug Administration approved in 2011 and is now widely used. Dedicated breast CT is the next technological advance, combining real 3-dimensional imaging with the ease of contrast administration. The lack of painful compression and manipulation of the breasts also makes dedicated breast CT much more acceptable for the patients.
AB - Dedicated breast computed tomography (CT) is the latest in a long history of breast imaging techniques dating back to the 1960s. Breast imaging is performed both for cancer screening as well as for diagnostic evaluation of symptomatic patients. Dedicated breast CT received US Food and Drug Administration approval for diagnostic use in 2015 and is slowly gaining recognition for its value in diagnostic 3-dimensional imaging of the breast, and also for injected contrast-enhanced imaging applications. Conventional mammography has known limitations in sensitivity and specificity, especially in dense breasts. Breast tomosynthesis was US Food and Drug Administration approved in 2011 and is now widely used. Dedicated breast CT is the next technological advance, combining real 3-dimensional imaging with the ease of contrast administration. The lack of painful compression and manipulation of the breasts also makes dedicated breast CT much more acceptable for the patients.
UR - http://www.scopus.com/inward/record.url?scp=85032741241&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85032741241&partnerID=8YFLogxK
U2 - 10.1053/j.sult.2017.09.001
DO - 10.1053/j.sult.2017.09.001
M3 - Article
C2 - 29317032
AN - SCOPUS:85032741241
SN - 0887-2171
VL - 39
SP - 106
EP - 113
JO - Seminars in Ultrasound, CT and MRI
JF - Seminars in Ultrasound, CT and MRI
IS - 1
ER -